Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthea J Stanley

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Proteomics|January 15, 2009
Using the protein chip interface with quadrupole time-of-flight mass spectrometry to directly identify peaks in SELDI profiles--initial evaluation using low molecular weight serum peaksJianhe Peng, Anthea J Stanley, David Cairns, et al.
Proteomics|December 21, 2007
Proteomic profiling using mass spectrometry--does normalising by total ion current potentially mask some biological differences?David A Cairns, Douglas Thompson, David N Perkins, et al.
Proteomics|November 13, 2008
Serum biomarker discovery in renal cancer using 2-DE and prefractionation by immunodepletion and isoelectric focusing; increasing coverage or more of the same?Naveen S Vasudev, Roisean E Ferguson, David A Cairns, et al.
Clinical Chemistry|July 9, 2005
Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometryRosamonde E Banks, Anthea J Stanley, David A Cairns, et al.
BMC Bioinformatics|December 6, 2008
Integrated multi-level quality control for proteomic profiling studies using mass spectrometryDavid A Cairns, David N Perkins, Anthea J Stanley, et al.
Proteomics. Clinical Applications|December 8, 2010
Changes in the urinary proteome post-operatively in renal cancer patients - a reflection of tumour or kidney removal?Sheryl H Sim, David A Cairns, David N Perkins, et al.
Proteomics. Clinical Applications|August 12, 2011
A pilot study to investigate the potential of mass spectrometry profiling in the discovery of novel serum markers in chronic renal diseaseDouglas Thompson, Willem Develter, David A Cairns, et al.
Proteomics|April 6, 2006
Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinomaRachel A Craven, Anthea J Stanley, Sarah Hanrahan, et al.
Proteomics|December 5, 2008
Sample size determination in clinical proteomic profiling experiments using mass spectrometry for class comparisonDavid A Cairns, Jennifer H Barrett, Lucinda J Billingham, et al.
Proteomics|June 2, 2006
Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinomaRachel A Craven, Sarah Hanrahan, Nick Totty, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Proteomics|January 15, 2009
Using the protein chip interface with quadrupole time-of-flight mass spectrometry to directly identify peaks in SELDI profiles--initial evaluation using low molecular weight serum peaksJianhe Peng, Anthea J Stanley, David Cairns, et al.
Proteomics|December 21, 2007
Proteomic profiling using mass spectrometry--does normalising by total ion current potentially mask some biological differences?David A Cairns, Douglas Thompson, David N Perkins, et al.
Proteomics|November 13, 2008
Serum biomarker discovery in renal cancer using 2-DE and prefractionation by immunodepletion and isoelectric focusing; increasing coverage or more of the same?Naveen S Vasudev, Roisean E Ferguson, David A Cairns, et al.
Clinical Chemistry|July 9, 2005
Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometryRosamonde E Banks, Anthea J Stanley, David A Cairns, et al.
BMC Bioinformatics|December 6, 2008
Integrated multi-level quality control for proteomic profiling studies using mass spectrometryDavid A Cairns, David N Perkins, Anthea J Stanley, et al.
Proteomics. Clinical Applications|December 8, 2010
Changes in the urinary proteome post-operatively in renal cancer patients - a reflection of tumour or kidney removal?Sheryl H Sim, David A Cairns, David N Perkins, et al.
Proteomics. Clinical Applications|August 12, 2011
A pilot study to investigate the potential of mass spectrometry profiling in the discovery of novel serum markers in chronic renal diseaseDouglas Thompson, Willem Develter, David A Cairns, et al.
Proteomics|April 6, 2006
Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinomaRachel A Craven, Anthea J Stanley, Sarah Hanrahan, et al.
Proteomics|December 5, 2008
Sample size determination in clinical proteomic profiling experiments using mass spectrometry for class comparisonDavid A Cairns, Jennifer H Barrett, Lucinda J Billingham, et al.
Proteomics|June 2, 2006
Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinomaRachel A Craven, Sarah Hanrahan, Nick Totty, et al.
Pageof 2